Αποτελέσματα Αναζήτησης
8 Σεπ 2023 · Company analysis report focuses on examining a company’s financial performance, shedding light on essential indicators such as revenue growth, profitability ratios, liquidity position, and efficiency metrics.
Q3'21 Financial Metrics. Revenues: $1.59B, +20.8% y/y core(1)(2),+25.8% reported (+4.5% FX, 0.5% M&A). Operating Margin: 26.0%(2) of revenue, up 230 basis points y/y. EPS: $1.10(2), up 41% y/y. Q3’21 Highlights • Growth was broad-based across all end markets and regions led by strength in Pharma and Dx & Clinical and sequential acceleration ...
Agilent Results FY’22. FY22 Financial Metrics. Revenues: $6.85B, +8.4% reported, +11.9% y/y core(1)(2) (-3.6% FX, +0.1% M&A). Operating Margin: 27.1%(2) of revenue, up 160 basis points y/y.
FY’21 Highlights. Growth was broad-based, with all markets and regions growing at least mid-single digits. The Pharma market was exceptionally strong with 24% growth, while the Americas delivered 21% growth to lead our regional results(1)(2).
Mordor Intelligence™ provides comprehensive insights into Agilent Technologies. Gain valuable industry research and analysis in this detailed company report.
Agilent Technologies Inc. analyst ratings, historical stock prices, earnings estimates & actuals. A updated stock price target summary.
Agilent Technologies Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Agilent Technologies Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Agilent Technologies Inc. or its management.
